Seminar on Nucleic Acid Drug Market Entry Strategy Looking Toward the 2030s
IR Technical Education Institute will hold a public seminar on July 16, 2026, to learn about patent trends and entry strategies for nucleic acid drugs.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 11:00
- 🔍 Collected: June 1, 2026 at 02:52 (63h 52m after Published)
- 🤖 AI Analyzed: June 1, 2026 at 20:00 (17h 7m after Collected)
The IR Technical Education Institute will hold a public seminar on July 16, 2026, to learn about patent trends and entry strategies for nucleic acid (RNA) drugs. While nucleic acid drugs are attracting attention as a next-generation modality, their patent structures are complex, requiring strategies that anticipate patent expirations in the 2030s. This course systematically explains the patent history of siRNA and ASO, as well as the competitive landscape of DDS technology, from the perspectives of intellectual property and CMC. It is aimed at R&D and IP personnel in pharmaceutical companies and bio-ventures.
FAQ
Can Taiwanese pharmaceutical companies participate?
Yes, as it is an online seminar, participation from overseas is possible.